Validation of Procalcitonin as a Biomarker Diagnosing CDI

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

December 1, 2011

Primary Completion Date

October 10, 2021

Study Completion Date

November 1, 2021

Conditions

Cardiac Implantable Electronic Device Infections

Interventions

OTHER

procalcitonin blood test

blood samples of all participants were analyzed for procalitonin levels, using a commercially available procalitonin testing kit

All Listed Sponsors

lead

Deutsches Herzzentrum Muenchen

OTHER

NCT05007158 - Validation of Procalcitonin as a Biomarker Diagnosing CDI | Biotech Hunter | Biotech Hunter